Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme;Ausgeprägt negativer prognostischer Einfluss von hyperglykämischen Episoden während der adjuvanten Radiochemotherapie des Glioblastoma multiforme

Strahlentherapie und Onkologie

Volumn 190, Issue 10, 2014, Pages 933-938

  Mayer, Arnulf ^a   Vaupel, Peter ^a   Struss, Hans Garlich ^a   Giese, Alf ^a   Stockinger, Marcus ^a   Schmidberger, Heinz ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Glioblastoma; Hyperglycemia; Overall survival; Temozolomide

Indexed keywords

GLUCOSE; TEMOZOLOMIDE;

ADJUVANT CHEMORADIOTHERAPY; ADULT; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DIABETES MELLITUS; DNA DAMAGE; FEMALE; GLIOBLASTOMA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOXIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; AGED; BRAIN NEOPLASMS; COMORBIDITY; EPIDEMIOLOGY; GERMANY; MORTALITY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CAUSALITY; CHEMORADIOTHERAPY, ADJUVANT; COMORBIDITY; FEMALE; GERMANY; GLIOBLASTOMA; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84919870853     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-014-0696-z     Document Type: Article

References (17)

1. Bonuccelli G, Tsirigos A, Whitaker-Menezes D et al (2010) Ketones and lactate “fuel” tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9:3506–3514
2. Curran WJ Jr., Scott CB, Horton J et al (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704–710
3. Derr RL, Ye X, Islas MU et al (2009) Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol 27:1082–1086
4. Jelluma N, Yang X, Stokoe D et al (2006) Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes. Mol Cancer Res 4:319–330
5. Li J, Ayene R, Ward KM et al (2009) Glucose deprivation increases nuclear DNA repair protein Ku and resistance to radiation induced oxidative stress in human cancer cells. Cell Biochem Funct 27:93–101
6. Mayer A, Schneider F, Vaupel P et al (2012) Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma. Int J Oncol 41:1260–1270
7. McGirt MJ, Chaichana KL, Gathinji M et al (2008) Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas. Neurosurgery 63:286–291; discussion 291
8. Mergenthaler P, Lindauer U, Dienel GA et al (2013) Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 36:587–597
9. Oudard S, Arvelo F, Miccoli L et al (1996) High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss. Br J Cancer 74:839–845
10. Sahm F, Capper D, Jeibmann A et al (2012) Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Arch Neurol 69:523–526
11. Sattler UG, Meyer SS, Quennet V et al (2010) Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 94:102–109
12. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
13. Vaupel P (2004) Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14:198–206
14. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49:6449–6465
15. Warburg O, Posener K, Negelein E (1924) Über den Stoffwechsel der Carcinomzelle. Biochem. Zeitschr. 152:309–344
16. Yamamori T, Meike S, Nagane M et al (2013) ER stress suppresses DNA double-strand break repair and sensitizes tumor cells to ionizing radiation by stimulating proteasomal degradation of Rad51. FEBS Lett 587:3348–3353
17. Yuan S, Wang F, Chen G et al (2013) Effective elimination of cancer stem cells by a novel drug combination strategy. Stem Cells 31:23–34